Cargando…

Formulation development of chewable albendazole tablets with improved dissolution rate

BACKGROUND: Albendazole is an orally administered broad-spectrum anthelmintic. Currently it is mostly used in the treatment of soil transmitted helminthes, hydatidosis and neurocysticercosis caused Taenia solium. Aim of the study. To develop and optimize a formulation of chewable albendazole tablet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimaro, Emmanuel, Tibalinda, Prosper, Shedafa, Raphael, Temu, Mary, Kaale, Eliangiringa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931076/ https://www.ncbi.nlm.nih.gov/pubmed/31890938 http://dx.doi.org/10.1016/j.heliyon.2019.e02911

Ejemplares similares

Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design
por: Tibalinda, Prosper, et al.
Publicado: (2016)

Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability
por: Sawatdee, Somchai, et al.
Publicado: (2019)

Dissolution enhancement of albendazole through nanocrystal formulation
por: Koradia, D. Krishna, et al.
Publicado: (2012)

Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021
por: Wande, Dickson Pius, et al.
Publicado: (2019)

Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010)

Soft-Chewable Paracetamol Tablets by Melt Granulation Method: Formulation and Characterization
por: Sabere, Awis Sukarni Mohmad, et al.
Publicado: (2021)

Formulation and optimisation of raft-forming chewable tablets containing H(2) antagonist
por: Prajapati, Shailesh T, et al.
Publicado: (2012)

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost
por: Costa, Enrico, et al.
Publicado: (2020)

Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets
por: Usmani, Muhammad Talha, et al.
Publicado: (2023)

Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers
por: Bunlung, Suputra, et al.
Publicado: (2021)

Development of a chewable tablet from Dugdhāmalakyādi Yoga: An Ayurvedic preparation
por: Santhosh, S. B., et al.
Publicado: (2012)

Dramatic improvement in dissolution rate of albendazole by a simple, one-step, industrially scalable technique
por: Ghanbarzadeh, Saeed, et al.
Publicado: (2016)

Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate
por: Esperanza Adrover, María, et al.
Publicado: (2020)

Tadalafil-Loaded Self-Nanoemulsifying Chewable Tablets for Improved Bioavailability: Design, In Vitro, and In Vivo Testing
por: Ali, Hany S. M., et al.
Publicado: (2022)

Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats
por: Fouad, Shahinaze A., et al.
Publicado: (2023)

Development of advantus™(imidacloprid) soft chewable tablets for the treatment of Ctenocephalides felis infestations on dogs
por: Qureshi, Tariq, et al.
Publicado: (2015)

Comparison of pharmacokinetic characteristics of sildenafil citrate chewable tablets and film-coated tablets in healthy male subjects
por: Yoo, Hyounggyoon, et al.
Publicado: (2017)

The Effect of Humidity on the Dissolution Kinetics and Tablet Properties of Immediate-Release Tablet Formulation Containing Lamotrigine
por: Lalić-Popović, Mladena, et al.
Publicado: (2022)

Acceptability of Mebendazole Chewable Tablet in Children Aged 2 to 4 Years in Peru
por: Perez, Fernando, et al.
Publicado: (2021)

Comparison of Dissolution Profiles and Serum Concentrations of Two Lamotrigine Tablet Formulations
por: Lalic, Mladena, et al.
Publicado: (2012)

Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability
por: Rahim, Haroon, et al.
Publicado: (2020)

Impact of Tablet Shape on Drug Dissolution Rate Through Immediate Released Tablets
por: Molavi, Fatima, et al.
Publicado: (2020)

Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™)
por: Kuntz, Emmanuelle A., et al.
Publicado: (2017)

Safety of lotilaner flavoured chewable tablets (Credelio(TM)) after oral administration in cats
por: Kuntz, Emmanuelle A., et al.
Publicado: (2018)

The Effect of Myristica fragrans on Texture Properties and Shelf-Life of Innovative Chewable Gel Tablets
por: Matulyte, Inga, et al.
Publicado: (2021)

Formulation of New Chewable Oral Dosage Forms of Meclizine and Pyridoxine Hydrochloride
por: Al-Madhagi, Wafa M., et al.
Publicado: (2023)

Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine
por: Musuc, Adina Magdalena, et al.
Publicado: (2021)

Development of Innovative Chewable Gel Tablets Containing Nutmeg Essential Oil Microcapsules and Their Physical Properties Evaluation
por: Matulyte, Inga, et al.
Publicado: (2021)

Development and Validation of a Dissolution Test for Meloxicam and Pridinol Mesylate from Combined Tablet Formulation
por: Vignaduzzo, S. E., et al.
Publicado: (2010)

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017)

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

Compounding Tailored Veterinary Chewable Tablets Close to the Point-of-Care by Means of 3D Printing
por: Sjöholm, Erica, et al.
Publicado: (2022)

Potential of flow injection analysis for dissolution tests: application to on-line monitoring of tablets with different dissolution rates
por: Cosano, J. S., et al.
Publicado: (1990)

Efficacy, safety and acceptability of a new chewable formulation versus the solid tablet of mebendazole against hookworm infections in children: An open-label, randomized controlled trial
por: Palmeirim, Marta S., et al.
Publicado: (2020)

Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs
por: Lebon, Wilfried, et al.
Publicado: (2016)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
por: Wigal, Sharon B., et al.
Publicado: (2017)

Efficacy of fluralaner chewable tablets (Bravecto(®)) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs
por: Petersen, Melissa, et al.
Publicado: (2023)

Comparative Evaluation of Liposomal Albendazole and Tablet-Albendazole Against Hepatic Cystic Echinococcosis: A Non-Randomized Clinical Trial
por: Li, Haitao, et al.
Publicado: (2016)

In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine
por: Incecayir, Tuba, et al.
Publicado: (2023)

The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug Formulation
por: Hattrem, Magnus N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ath3o139tm0ftbpje3h91j5b12